| Literature DB >> 5808010 |
Abstract
Sixteen patients in whom schizophrenia was initially diagnosed and who were treated with fluphenazine enanthate or decanoate developed severe depression for a short period after the injection. In five cases this depression is thought to have been responsible for suicide. In 8 out of 10 cases the depression responded to electroplexy (E.C.T.). It is recommended that patients who are treated with fluphenazine should be carefully supervised.Entities:
Mesh:
Substances:
Year: 1969 PMID: 5808010 PMCID: PMC1984352 DOI: 10.1136/bmj.3.5670.564
Source DB: PubMed Journal: Br Med J ISSN: 0007-1447